Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Majlessi, L.
Right arrow Articles by Bordenave, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Majlessi, L.
Right arrow Articles by Bordenave, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol 9, 1053-1060, Copyright © 1997 by Oxford University Press


ARTICLES

Breakdown of T cell tolerance to IgG2ab in Igha mice by de novo emerging anti-IgG2ab T cells and not anergy reversion

L Majlessi, N Rujithamkul, O Burlen-Defranoux and G Bordenave
Unite d'Immunophysiologie Moleculaire, Institut Pasteur, Paris, France.

The intrinsic T cell activity of Igha mice against IgG2ab (IgG2a from the Ighb haplotype) can be subjected to profound specific tolerance. In utero followed by post-natal exposure of Igha mice to soluble IgG2ab results in the loss of the capacity of their T splenocytes to induce specific and chronic IgG2ab allotype suppression in histocompatible Igha/b recipients. However, this full T cell tolerance has not been definitively acquired as it is spontaneously reversed when investigated 3-6 months after the end of the tolerogen treatment. Even when the IgG2ab tolerogen treatment was prolonged to 3, 6 or 9 months of age, T cell tolerance to IgG2ab vanished and the capacity of Igha T splenocytes to induce IgG2ab suppression in Igha/b recipients was systematically restored. The marked but partial thymus involution in 15- month-old Igha mice suggests the existence of some residual thymic output, capable of repopulating the anti-IgG2ab peripheral T pool subsequent to tolerogen clearance. In the present study, we showed that the mechanisms of this tolerance and its reversion involve, at the end of tolerogen treatment, the physical elimination or the irreversible inactivation of natural anti-IgG2ab T cell clones and their replacement, but neither the establishment of reversible anergy nor the recruitment of T cells which could actively maintain tolerance. The spontaneous breakdown of this T cell unresponsiveness was effectively prevented when de novo T cell maturation was inhibited by thymectomy at the end of tolerogen administration. Moreover, tolerance reversion did not occur in peripheral mature Igha T cells, parked in vivo, for up to 20 weeks in histocompatible tolerogen-free nu/nu mice.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Faure, S. Calbo, J. Kanellopoulos, A.-M. Drapier, P.-A. Cazenave, and D. Rueff-Juy
Tolerance to Maternal Immunoglobulins: Resilience of the Specific T Cell Repertoire in Spite of Long-Lasting Perturbations
J. Immunol., December 15, 1999; 163(12): 6511 - 6519.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.